Eiger BioPharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Palo Alto, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Eiger BioPharmaceuticals, Inc. has filed 694 SEC EDGAR filings since 05 Oct 2004

SEC filing history

Showing 501-525 of 687 matching filings.

Per page
25
Current page
21
CORRESP

CORRESP filing

Filing date
22 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-4/A File 333-208521

FORM S-4/A

Filing date
22 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

8-K

Filing date
19 Jan 2016
Reporting date
19 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-36183

8-K

Filing date
19 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
14 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87931

SC 13G/A

Filing date
07 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

FORM 8-K

Filing date
06 Jan 2016
Reporting date
06 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-36183

FORM 8-K

Filing date
06 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87931

SCHEDULE 13G/A

Filing date
05 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87931

SC 13G

Filing date
24 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-36183

425

Filing date
16 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

FORM 8-K

Filing date
16 Dec 2015
Reporting date
15 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-36183

FORM 8-K

Filing date
16 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

FORM 8-K

Filing date
01 Dec 2015
Reporting date
30 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-36183

FORM 8-K

Filing date
01 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

FORM 8-K

Filing date
23 Nov 2015
Reporting date
19 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-36183

FORM 8-K

Filing date
23 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

FORM 8-K

Filing date
19 Nov 2015
Reporting date
16 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-36183

FORM 8-K

Filing date
19 Nov 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

FORM 8-K

Filing date
30 Sep 2015
Reporting date
25 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

FORM 8-K

Filing date
15 Sep 2015
Reporting date
10 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

FORM 8-K

Filing date
11 Aug 2015
Reporting date
11 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .